Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE).


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
06 2023
Historique:
medline: 24 5 2023
pubmed: 22 5 2023
entrez: 22 5 2023
Statut: ppublish

Résumé

Long-term outcomes are unknown in patients with asymptomatic moyamoya disease. In this report, we aimed to clarify their 5-year risk of stroke and its predictors. We are conducting a multicenter, prospective cohort study (Asymptomatic Moyamoya Registry) in Japan. Participants were eligible if they were 20 to 70 years, had bilateral or unilateral moyamoya disease, experienced no episodes suggestive of TIA and stroke; and were functionally independent (modified Rankin Scale score 0-1). Demographic and radiological information was collected at enrollment. In this study, they are still followed up for 10 years. In this interim analysis, we defined the primary end point as a stroke occurring during a 5-year follow-up period. Independent predictors for stroke were also determined, using a stratification analysis method. Between 2012 and 2015, we enrolled 109 patients, of whom 103 patients with 182 involved hemispheres completed the 5-year follow-up. According to the findings on DSA and MRA, 143 hemispheres were judged as moyamoya disease and 39 hemispheres as questionable manifestations (isolated middle cerebral artery stenosis). The patients with questionable hemispheres were significantly older, more often male, and more frequently had hypertension than those with moyamoya hemisphere. Moyamoya hemispheres developed 7 strokes, including 6 hemorrhagic and 1 ischemic stroke, during the first 5 years. The annual risk of stroke was 1.4% per person, 0.8% per hemisphere, and 1.0% per moyamoya hemisphere. Independent predictor for stroke was Grade-2 choroidal anastomosis (hazard ratio, 5.05 [95% CI, 1.24-20.6]; The hemispheres with asymptomatic moyamoya disease may carry a 1.0% annual risk of stroke during the first 5 years, the majority of which are hemorrhagic stroke. Grade-2 choroidal anastomosis may predict stroke, and the microbleeds and Grade-2 choroidal anastomosis may carry the risk for hemorrhagic stroke. URL: https://www. gov; Unique identifier: UMIN000006640.

Sections du résumé

BACKGROUND
Long-term outcomes are unknown in patients with asymptomatic moyamoya disease. In this report, we aimed to clarify their 5-year risk of stroke and its predictors.
METHODS
We are conducting a multicenter, prospective cohort study (Asymptomatic Moyamoya Registry) in Japan. Participants were eligible if they were 20 to 70 years, had bilateral or unilateral moyamoya disease, experienced no episodes suggestive of TIA and stroke; and were functionally independent (modified Rankin Scale score 0-1). Demographic and radiological information was collected at enrollment. In this study, they are still followed up for 10 years. In this interim analysis, we defined the primary end point as a stroke occurring during a 5-year follow-up period. Independent predictors for stroke were also determined, using a stratification analysis method.
RESULTS
Between 2012 and 2015, we enrolled 109 patients, of whom 103 patients with 182 involved hemispheres completed the 5-year follow-up. According to the findings on DSA and MRA, 143 hemispheres were judged as moyamoya disease and 39 hemispheres as questionable manifestations (isolated middle cerebral artery stenosis). The patients with questionable hemispheres were significantly older, more often male, and more frequently had hypertension than those with moyamoya hemisphere. Moyamoya hemispheres developed 7 strokes, including 6 hemorrhagic and 1 ischemic stroke, during the first 5 years. The annual risk of stroke was 1.4% per person, 0.8% per hemisphere, and 1.0% per moyamoya hemisphere. Independent predictor for stroke was Grade-2 choroidal anastomosis (hazard ratio, 5.05 [95% CI, 1.24-20.6];
CONCLUSIONS
The hemispheres with asymptomatic moyamoya disease may carry a 1.0% annual risk of stroke during the first 5 years, the majority of which are hemorrhagic stroke. Grade-2 choroidal anastomosis may predict stroke, and the microbleeds and Grade-2 choroidal anastomosis may carry the risk for hemorrhagic stroke.
REGISTRATION
URL: https://www.
CLINICALTRIALS
gov; Unique identifier: UMIN000006640.

Identifiants

pubmed: 37216455
doi: 10.1161/STROKEAHA.122.041932
doi:

Banques de données

UMIN-CTR
['UMIN000006640']

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1494-1504

Investigateurs

Motoki Inaji (M)
Kenichi Morita (K)
Daisuke Maruyama (D)
Jyoji Nakagawara (J)
Naoki Hashimura (N)
Eika Hamano (E)
Koji Iihara (K)
Nobuo Hashimoto (N)
Kaori Honjo (K)
Hirohiko Nakamura (H)
Daina Kashiwazaki (D)
Hideaki Imai (H)
Satoru Miyawaki (S)
Hiroki Hongo (H)
Kazumichi Yoshida (K)
Takayuki Kikuchi (T)
Yohei Mineharu (Y)
Makoto Isozaki (M)
Kenichiro Kikuta (K)
Yoshio Araki (Y)
Fumiaki Kanamori (F)
Isao Date (I)
Junichi Ono (J)
Toshio Machida (T)
Mitsuhito Mase (M)
Hiroyuki Katano (H)
Koji Yamaguchi (K)
Takakazu Kawamata (T)
Teiji Tominaga (T)
Haruto Uchino (H)
Kikutaro Tokairin (K)
Masaki Ito (M)
Kiyohiro Houkin (K)
Kohei Chida (K)
Kuniaki Ogasawara (K)
Izumi Nagata (I)
Nobutaka Horie (N)
Hidehiro Oka (H)
Toshihiro Kumabe (T)
Yoshiaki Itoh (Y)
Takato Abe (T)
Koichi Oki (K)
Shinichi Takahashi (S)
Norihiro Suzuki (N)

Auteurs

Satoshi Kuroda (S)

Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan (S.K., S.Y., E.H.).

Shusuke Yamamoto (S)

Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan (S.K., S.Y., E.H.).

Takeshi Funaki (T)

Department of Neurosurgery, Kyoto University Graduate School of Medicine, Japan (T.F., S.M.).

Miki Fujimura (M)

Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan (M.F.).

Hiroharu Kataoka (H)

Department of Neurosurgery, National Cerebral and Cardiovascular Center, Suita, Japan (H.K.).

Tomohito Hishikawa (T)

Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Japan (T.H.).

Jun Takahashi (J)

Department of Neurosurgery, Kindai University School of Medicine, Sayama, Japan (J.T.).

Hidenori Endo (H)

Department of Neurosurgery, Kohnan Hospital, Sendai, Japan (H.E.).

Tadashi Nariai (T)

Department of Neurosurgery, Tokyo Medical and Dental University, Japan (T.N.).

Toshiaki Osato (T)

Department of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Japan (T.O.).

Nobuhito Saito (N)

Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, Japan (N. Saito).

Norihiro Sato (N)

Clinical Research and Medical Innovation Center (N. Sato), Hokkaido University Hospital, Sapporo, Japan.

Emiko Hori (E)

Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan (S.K., S.Y., E.H.).

Yoichi M Ito (YM)

Data Science Center, Promotion Unit, Institute of Health Science Innovation for Medical Care (Y.M.I.), Hokkaido University Hospital, Sapporo, Japan.

Susumu Miyamoto (S)

Department of Neurosurgery, Kyoto University Graduate School of Medicine, Japan (T.F., S.M.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH